The antecedents of biliary cancer: A primary care case-control study in the United Kingdom

British Journal of Cancer

Volumn 100, Issue 1, 2009, Pages 178-180

  Grainge, M J ^a   West, J ^a   Solaymani Dodaran, M ^a,c   Aithal, G P ^b   Card, T R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholangiocarcinoma; Database study; Gall bladder cancer; Non steroidal anti inflammatory drugs; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BILE DUCT CARCINOMA; BODY MASS; CANCER RISK; CHOLELITHIASIS; CHRONIC LIVER DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DRUG USE; FEMALE; GALLBLADDER CANCER; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; UNITED KINGDOM;

AGED; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 58149250411     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604765     Document Type: Article

References (14)

1. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, Martelli C, Savio A, Trevisi P, Nardi G (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12: 959-964
2. Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, Adami HO (1993) Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 342: 1262-1265
3. Hollowell J (1997) The General Practice Research Database: quality of morbidity data. Popul Trends 87: 36-40
4. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 320: 1642-1646
5. Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD (2007) Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 11: 1488-1496; discussion 1496-1497
6. Serra I, Calvo A, Baez S, Yamamoto M, Endoh K, Aranda W (1996) Risk factors for gallbladder cancer - an international collaborative case-control study. Cancer 78: 1515-1516
7. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102: 1016-1021
8. Sirica AE, Lai GH, Zhang Z (2001) Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies. J Gastroenterol Hepatol 16: 363-372
9. Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350: 1097-1099
10. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5: 1221-1228
11. West J, Wood H, Logan RF, Quinn M, Aithal GP (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 94: 1751-1758
12. Wu GS, Wang JH, Liu ZR, Zou SQ (2002) Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 1: 429-433
13. Wu GS, Zou SQ, Liu ZR, Tang ZH, Wang JH (2003) Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. World J Gastroenterol 9: 1302-1306
14. Yagyu K, Kikuchi S, Obata Y, Lin YS, Ishibashi T, Kurosawa M, Inaba Y, Tamakoshi A (2008) Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan. Int J Cancer 122: 924-929